Retraction notices

Suppression of the xCT-CD44v antiporter system sensitizes triple-negative breast cancer cells to doxorubicin

Type

Retraction

Notice date

5/1/2015 0:00

Journal

Breast Cancer Research and Treatment

Publisher

Springer

Notice DOI

10.1007/s10549-015-3399-y

Original paper DOI

10.1007/s10549-014-3068-6

Reasons

• Misconduct by Company/Institution
• Objections by Company/Institution

Matching venue names

Name match only, not an authoritative journal identifier.

• Breast Cancer Research and Treatment